Related Experiment Videos
Structure-activity relationships of recombinant hirudins
1Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Germany.
Seminars in Thrombosis and Hemostasis
|April 1, 1991
Summary
Hirudin binding to thrombin is unique, differing from other serine proteinase inhibitors. Its distinct interactions, not just ionic ones, explain hirudin's specific and strong inhibition of thrombin.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Thrombin is a key enzyme in blood coagulation.
- Serine proteinase inhibitors (serpins) typically bind to enzyme active sites.
- Hirudin is a potent thrombin inhibitor with unique binding characteristics.
Purpose of the Study:
- To elucidate the unique complex formation between thrombin and hirudin.
- To compare hirudin's binding mechanism with other serpins and inhibitors like D-Phe-Pro-ArgCH2Cl and NAPAP.
- To understand the structural basis for hirudin's high selectivity and affinity for thrombin.
Main Methods:
- Structural analysis of enzyme-inhibitor complexes.
- Comparison of binding modes of different inhibitors to thrombin.
- Analysis of protein-protein interactions at the molecular level.
Main Results:
- Hirudin's Thr2 residue interacts with the entrance of thrombin's active site pocket, unlike serpins that occupy it.
- Hirudin's N-terminal amino acids exhibit parallel orientation to the enzyme backbone, contrasting with antiparallel orientations of other inhibitors.
- Non-ionic interactions, particularly those involving hirudin's unique binding mode, contribute significantly to tight binding, surpassing ionic interactions with the fibrinogen binding site.
Conclusions:
- Hirudin's binding mechanism is distinct from other serine proteinase inhibitors.
- The unique interactions of hirudin with thrombin are responsible for its high affinity and specificity.
- Understanding these interactions provides insights into targeted anticoagulation therapy.